These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1260337)

  • 1. Response and survival in advanced breast cancer after two non-cross-resistant combinations.
    Brambilla C; De Lena M; Rossi A; Valagussa P; Bonadonna G
    Br Med J; 1976 Apr; 1(6013):801-4. PubMed ID: 1260337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer.
    De Lena M; Brambilla C; Morabito A; Bonadonna G
    Cancer; 1975 Apr; 35(4):1108-15. PubMed ID: 1116104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential combination chemotherapy in advanced breast cancer.
    Brambilla C; Valagussa P; Bonadonna G
    Cancer Chemother Pharmacol; 1978; 1(1):35-9. PubMed ID: 373906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of induction chemotherapies for metastatic breast cancer. An Eastern Cooperative Oncology Group Trial.
    Tormey DC; Gelman R; Band PR; Sears M; Rosenthal SN; DeWys W; Perlia C; Rice MA
    Cancer; 1982 Oct; 50(7):1235-44. PubMed ID: 7049347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project.
    Smalley RV; Carpenter J; Bartolucci A; Vogel C; Krauss S
    Cancer; 1977 Aug; 40(2):625-32. PubMed ID: 329975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Encouraging results with cytostatic therapy in metastasizing breast cancer (author's transl)].
    Michlmayr G; Kratzer H; Denz H; Huber H
    Wien Klin Wochenschr; 1981 Mar; 93(6):205-7. PubMed ID: 7281697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
    Smalley RV; Bartolucci AA
    Eur J Cancer (1965); 1980; Suppl 1():141-6. PubMed ID: 7318861
    [No Abstract]   [Full Text] [Related]  

  • 8. Vincristine, doxorubicin, and cyclophosphamide versus low-dose intravenous cyclophosphamide, methotrexate, and 5-fluorouracil in advanced breast cancer: a randomized trial of the Piedmont Oncology Association.
    Muss HB; Richards F; Jackson DV; Cooper MR; White DR; Stuart JJ; Ramseur W; Christian RM; Wells HB; Pope E; Spurr CL
    Cancer; 1982 Dec; 50(11):2269-74. PubMed ID: 6754062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy for advanced breast cancer: two regimens containing adriamycin.
    Kennealey GT; Boston B; Mitchell MS; Knobf MK; Bobrow SN; Pezzimenti JF; Lawrence R; Bertino JR
    Cancer; 1978 Jul; 42(1):27-33. PubMed ID: 667798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy and adriamycin in patients with advanced breast cancer. A Southwest Oncology Group study.
    Hoogstraten B; George SL; Samal B; Rivkin SE; Costanzi JJ; Bonnet JD; Thigpen T; Braine H
    Cancer; 1976 Jul; 38(1):13-20. PubMed ID: 947510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled evaluation of adriamycin (NSC-123127) in patients with disseminated breast cancer.
    Ahmann DL; Bisel HF; Eagan RT; Edmonson JH; Hahn RG
    Cancer Chemother Rep; 1974; 58(6):877-82. PubMed ID: 4614896
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapy for breast cancer.
    Allegra JC; Lippman ME
    Compr Ther; 1979 Feb; 5(2):13-7. PubMed ID: 428200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy.
    Bull JM; Tormey DC; Li SH; Carbone PP; Falkson G; Blom J; Perlin E; Simon R
    Cancer; 1978 May; 41(5):1649-57. PubMed ID: 348293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new six-drug antiblastic regimen (R 14) at low doses (micropolychemotherapy) compared to CMF in the treatment of metastatic breast cancer: phase III study.
    Pannuti F; Iafelice G; Martoni A; Fruet F; Angelelli B; Casadei M
    Chemioterapia; 1984 Aug; 3(4):216-9. PubMed ID: 6398121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of adriamycin in metastatic breast cancer resistant to a combination regimen with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prdnisone.
    Frederiksen PL; Joergensen ST; Roesdahl K; Thomsen J; Mouridsen HT
    Cancer Treat Rep; 1978 Mar; 62(3):449-50. PubMed ID: 348314
    [No Abstract]   [Full Text] [Related]  

  • 16. Adriamycin alone or combined with vincristine in the treatment of advanced breast cancer.
    Steiner R; Stewart JF; Cantwell BM; Minton MJ; Knight RK; Rubens RD
    Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1553-7. PubMed ID: 6357805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined chemo- and hormonal therapy in advanced breast cancer.
    Brunner KW; Sonntag RW; Alberto P; Senn HJ; Martz G; Obrecht P; Maurice P
    Cancer; 1977 Jun; 39(6 Suppl):2923-33. PubMed ID: 326385
    [No Abstract]   [Full Text] [Related]  

  • 18. Adriamycin in combination for the treatment of breast cancer: a Southwest Oncology Group study.
    Tranum B; Hoogstraten B; Kennedy A; Vaughn CB; Samal B; Thigpen T; Rivkin S; Smith F; Palmer RL; Costanzi J; Tucker WG; Wilson H; Maloney TR
    Cancer; 1978 Jun; 41(6):2078-83. PubMed ID: 657081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy of metastatic carcinoma of the breast. A 4-drug regimen.
    Mattsson W; Gynning I; Tropé C; Astedt B
    Acta Radiol Ther Phys Biol; 1977 Apr; 16(2):97-108. PubMed ID: 301341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
    Mouridsen HT; Palshof T
    Prog Clin Biol Res; 1977; 12():459-66. PubMed ID: 335404
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.